Intravenous immunoglobulin therapy (IVIG) is effective for patients with primary immunodeficiency disease (PIDD), but infection is still possible. In this retrospective analysis, medical and pharmacy claims were used to assess the economic impact of infections over 7 months in patients with PIDD who received any commercially available IVIG and who experience an infection (N0490). Bacterial infections were experienced by 28.2% of patients had a bacterial infection. The predominant infection-related resource use was outpatient care (89.8 % had ≥ 1 infection-related visit), followed by hospitalization (25.3 %), and emergency department visit (4.5 %). Mean total infection-related cost was $8684/patient (±$31,767), with the highest being hospitalization ($25,487±$55,164). Since infection-related costs for PIDD patients who experience an infection can be substantial, cost studies of optimizing Ig dose by adjusted dosing or sustained steady state levels must include evaluation of infection-related medical costs.
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